ISOCARBOXAZID

ISOCARBOXAZID was reported 94 times

ISOCARBOXAZID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREATH ALCOHOL TEST POSITIVE 1 0.0044
1 SOMATIC DELUSION 1 0.0041
2 PITTING OEDEMA 1 0.0016
3 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 1 0.0014
4 STRESS CARDIOMYOPATHY 7 0.0012
5 THALAMUS HAEMORRHAGE 1 0.0011
6 JOINT CONTRACTURE 1 0.0009
7 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
8 GENITAL PAIN 1 0.0007
9 BIPOLAR I DISORDER 1 0.0005
10 EXCORIATION 1 0.0004
11 SEROTONIN SYNDROME 7 0.0004
12 HYPERCAPNIA 1 0.0003
13 MICTURITION DISORDER 1 0.0003
14 PAROSMIA 2 0.0003
15 HAEMORRHAGIC STROKE 2 0.0003
16 TRICUSPID VALVE INCOMPETENCE 2 0.0003
17 HYPERPHAGIA 1 0.0003
18 HOMICIDAL IDEATION 1 0.0002
19 GOITRE 1 0.0002
20 DYSPHEMIA 1 0.0002
21 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
22 COMPLETED SUICIDE 17 0.0002
23 NYSTAGMUS 1 0.0002
24 MITRAL VALVE INCOMPETENCE 2 0.0002
25 MUSCLE TWITCHING 4 0.0002
26 TENSION 1 0.0002
27 PRODUCT COMPLAINT 4 0.0002
28 INCOHERENT 1 0.0002
29 PULMONARY HYPERTENSION 3 0.0001
30 CEREBRAL DISORDER 1 0.0001
31 FEELING DRUNK 1 0.0001
32 PEMPHIGOID 1 0.0001
33 HALLUCINATION, AUDITORY 2 0.0001
34 COAGULOPATHY 2 0.0001
35 THIRST 2 0.0001
36 PERSONALITY CHANGE 1 0.0001
37 FEELING JITTERY 2 0.0001
38 MOTOR DYSFUNCTION 1 0.0001
39 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
40 VENTRICULAR FIBRILLATION 1 0.0001
41 URINARY RETENTION 3 0.0001
42 REBOUND EFFECT 1 0.0001
43 PRODUCT AVAILABILITY ISSUE 2 0.0001
44 MYOCLONUS 1 0.0001
45 MUSCLE RIGIDITY 1 0.0001
46 POLYNEUROPATHY 1 0.0001
47 ERECTILE DYSFUNCTION 2 0.0001
48 PRODUCT TASTE ABNORMAL 1 0.0001
49 PERIPHERAL COLDNESS 1 0.0001
50 MENTAL STATUS CHANGES 2 0.0001
51 COORDINATION ABNORMAL 1 0.0001
52 HYPERTHYROIDISM 1 0.0001
53 ACUTE MYOCARDIAL INFARCTION 2 0.0001
54 CARDIOMYOPATHY 1 0.0001
55 MUSCLE TIGHTNESS 1 0.0001
56 TOXICITY TO VARIOUS AGENTS 10 0.0001
57 ORTHOSTATIC HYPOTENSION 1 0.0001
58 NERVOUSNESS 3 0.0001
59 SPEECH DISORDER 3 0.0001
60 THINKING ABNORMAL 1 0.0001
61 MIDDLE INSOMNIA 1 0.0001
62 DYSARTHRIA 2 0.0001
63 BLOOD SODIUM DECREASED 1 0.0001
64 PRESCRIBED OVERDOSE 1 0.0001
65 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
66 POLLAKIURIA 2 0.0000
67 HALLUCINATION, VISUAL 1 0.0000
68 EATING DISORDER 1 0.0000
69 PULMONARY OEDEMA 2 0.0000
70 THROAT IRRITATION 2 0.0000
71 SUICIDAL IDEATION 4 0.0000
72 PRESYNCOPE 1 0.0000
73 ENCEPHALOPATHY 1 0.0000
74 HYPERHIDROSIS 5 0.0000
75 DIPLOPIA 1 0.0000
76 INSOMNIA 10 0.0000
77 DRY MOUTH 3 0.0000
78 MOOD ALTERED 1 0.0000
79 VISION BLURRED 5 0.0000
80 HAEMOPTYSIS 1 0.0000
81 WOUND 1 0.0000
82 ANGINA PECTORIS 1 0.0000
83 ASCITES 1 0.0000
84 WHEEZING 2 0.0000
85 APHASIA 1 0.0000
86 SWOLLEN TONGUE 1 0.0000
87 SKIN DISORDER 1 0.0000
88 CHEST DISCOMFORT 3 0.0000
89 DELIRIUM 1 0.0000
90 RASH MACULAR 1 0.0000
91 SLEEP DISORDER 2 0.0000
92 PANIC ATTACK 1 0.0000
93 RESTLESSNESS 1 0.0000
94 AGITATION 2 0.0000
95 BLOOD PRESSURE INCREASED 4 0.0000
96 PALPITATIONS 3 0.0000
97 ABNORMAL BEHAVIOUR 1 0.0000
98 DRUG INTERACTION 4 0.0000
99 CONFUSIONAL STATE 4 0.0000
100 BALANCE DISORDER 2 0.0000
101 MENTAL DISORDER 1 0.0000
102 DRUG WITHDRAWAL SYNDROME 2 0.0000
103 WEIGHT INCREASED 5 0.0000
104 DEPRESSION 5 0.0000
105 MUSCLE SPASMS 4 0.0000
106 ADVERSE EVENT 2 0.0000
107 COGNITIVE DISORDER 1 0.0000
108 DYSPHAGIA 2 0.0000
109 AGGRESSION 1 0.0000
110 HYPOTENSION 4 0.0000
111 ECZEMA 1 0.0000
112 DISTURBANCE IN ATTENTION 1 0.0000
113 OEDEMA 1 0.0000
114 NECK PAIN 1 0.0000
115 BLISTER 1 0.0000
116 OXYGEN SATURATION DECREASED 1 0.0000
117 HYPONATRAEMIA 1 0.0000
118 EYE IRRITATION 1 0.0000
119 FEELING ABNORMAL 4 0.0000
120 THERAPEUTIC RESPONSE DECREASED 1 0.0000
121 STOMATITIS 1 0.0000
122 OEDEMA PERIPHERAL 2 0.0000
123 SWELLING FACE 1 0.0000
124 INJURY 1 0.0000
125 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
126 DIZZINESS 7 0.0000
127 THERAPY INTERRUPTED 1 0.0000
128 MALAISE 6 0.0000
129 HYPOAESTHESIA 2 0.0000
130 HALLUCINATION 1 0.0000
131 ARTHRITIS 1 0.0000
132 CARDIAC FAILURE CONGESTIVE 1 0.0000
133 CARDIAC ARREST 1 0.0000
134 TREATMENT FAILURE 1 0.0000
135 TREMOR 2 0.0000
136 MYOCARDIAL INFARCTION 2 0.0000
137 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
138 MUSCULOSKELETAL STIFFNESS 1 0.0000
139 ADVERSE DRUG REACTION 1 0.0000
140 CARDIAC DISORDER 1 0.0000
141 PRODUCT USE ISSUE 2 0.0000
142 DRUG INEFFECTIVE 14 0.0000
143 BLOOD GLUCOSE INCREASED 2 0.0000
144 ANXIETY 3 0.0000
145 NEUROPATHY PERIPHERAL 1 0.0000
146 PRURITUS 4 0.0000
147 HEART RATE INCREASED 1 0.0000
148 SYNCOPE 1 0.0000
149 HYPERTENSION 2 0.0000
150 CONSTIPATION 2 0.0000
151 ASTHMA 1 0.0000
152 MUSCULAR WEAKNESS 1 0.0000
153 VISUAL IMPAIRMENT 1 0.0000
154 HEADACHE 5 0.0000
155 LOSS OF CONSCIOUSNESS 1 0.0000
156 PRODUCT QUALITY ISSUE 1 0.0000
157 CONDITION AGGRAVATED 2 0.0000
158 PAIN 4 0.0000
159 PARAESTHESIA 1 0.0000
160 DIARRHOEA 4 0.0000
161 PNEUMONIA 2 0.0000
162 FALL 2 0.0000
163 ABDOMINAL DISCOMFORT 1 0.0000
164 NASOPHARYNGITIS 1 0.0000
165 CHEST PAIN 1 0.0000
166 HYPERSENSITIVITY 1 0.0000
167 DYSPNOEA 3 0.0000
168 GAIT DISTURBANCE 1 0.0000
169 NAUSEA 4 0.0000
170 ABDOMINAL PAIN UPPER 1 0.0000
171 OVERDOSE 1 0.0000
172 RASH 2 0.0000
173 INCORRECT DOSE ADMINISTERED 1 0.0000
174 ABDOMINAL PAIN 1 0.0000
175 FATIGUE 3 0.0000
176 PAIN IN EXTREMITY 1 0.0000
177 OFF LABEL USE 2 0.0000
178 DEATH 1 0.0000